ask our doctors

Lymphoma Diffuse Large Cell

Get the facts on Lymphoma Diffuse Large Cell treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Lymphoma Diffuse Large Cell prevention, screening, research, statistics and other Lymphoma Diffuse Large Cell related topics. We answer all your qestions about Lymphoma Diffuse Large Cell.

Question: My uncle has diffuse large cell lymphoma? I'm extremely close to my uncle. Since my dad left us when I was very young, he acted as my father figure, best friend, and beyond. My mother has just recently told me that my uncle, now in his 50s, was diagnosed with diffuse large cell lymphoma and had been fighting it ever since Winter of 2008. Currently he's in critical condition, and is also battling a lung infection because his immune system has been completely destroyed by the cancer. Please, if you know anything about this type of lymphoma, tell me anything you know and what the chances of survival are. I can't afford to lose him.

Answer: Diffuse Large B-Cell Lymphomas (DLBCL) A cancer of b-cells (lymphocytes) that normally reside in the lymphatic system. The word "diffuse" describes the cell pattern. B-cells arise from the bone marrow and mature or differentiate into many cell types that tend to migrate to different areas of the body. What is lymphoma? Briefly, lymphomas result when damage to DNA occurs to a type of white blood cell (a lymphocyte) that results in the abnormal production of proteins that prevents the cells from dying when they should, or causes sustained rapid cell division. These malignant cells then may accumulate to form tumors that may enlarge the lymph nodes or spread to other areas of the lymphatic system, such as the spleen or bone marrow. Lymphoma cells can also migrate to, or first appear, outside the lymphatic system. Lymphoma that presents outside the lymphatic system is called extranodal disease. For details, see What's Lymphoma & Lymphoma simplified. Initial presentation: DLBCL typically presents as a nodal or extranodal (outside the lymphatic system) mass with fast tumour growth associated with systemic symptoms, such as sweats, fatigue, and fever. In about 40% of cases, these lymphomas appear in areas outside lymph nodes, including digestive tract, skin, bone, thyroid, and testes. Staging: Staging refers to the how widespread the disease is. Imaging tests (CT MRI, PET, Gallium) and bone marrow biopsies are commonly done to estimate this. See Staging for more detail.


Lymphoma Diffuse Large Cell News

Cell Therapeutics Withdraws New Drug Application for Pixuvri(TM) and Plans to ...

MarketWatch (press release)
These novel pharmacologic differences may allow re-introduction of anthracycline-like potency in the treatment of relapsed/refractory diffuse large cell lymphoma without unacceptable rates of cardiotoxicity. Headquartered in Seattle, CTI is a ...
 

ZEVALIN Plus High Dose Chemotherapy (Z-BEAM) Highly Effective in Aggressive ...

MarketWatch (press release)
The current clinical program includes a Phase 3 study in Diffuse Large B-Cell Lymphoma, and a trial to evaluate ZEVALIN in previously untreated follicular non-Hodgkin's lymphoma patients. "This study highlights a major advance for DLBCL and other ...
 

Another Year, Another High...

NASDAQ
A number of phase 1 and 2 studies with PCI-32765 are ongoing across a panel of B-cell malignancy disorders, including chronic lymphocytic leukemia, mantle cell lymphoma, and diffuse large B-cell lymphoma. Last December, the company presented interim ...
 

Nodal Marginal Zone Lymphoma: Impersonalized Medicine

Cancer Network
For example, it is now appreciated that the stromal signatures of diffuse large B-cell lymphomas and the microenvironment of chronic lymphocytic leukemia contribute significantly to tumor behavior by cooperating with the ability of a cancer's cells to ...
 

Burton Mail

Determined not to quit ? cancer survivor's ambition
Burton Mail
 

Independent Online

Med schemes can say no to super drugs
Independent Online
 

Somatic mutations in histone H3 in pediatric brain tumors

Nature.com (blog)
... transitional cell carcinoma of the bladder, histone methyltransferase EZH2 in follicular and diffuse large B-cell lymphoma and myeloid disorders, DNMT3A in AML, ARID2 in hepatocellular carcinoma, MLL2 in DLBCL, and ARID1a in gastric cancer) it is ...
 

ImmunoGen, Inc. Reports Second Quarter Fiscal Year 2012 Financial Results and ...

MarketWatch (press release)
Phase II trials are now in process that evaluate SAR3419: (1) as a single agent for diffuse large B-cell lymphoma (DLBCL); (2) in combination with Rituxan(R) (rituximab) for DLBCL; and (3) as a single agent for B-cell acute lymphoblastic leukemia ...
 

Amgen Offers $1.16B for Antibody Firm Micromet

BioWorld Online
In a separate presentation, Micromet said Phase I data showed blinatumomab induced durable responses in patients with extensively pretreated diffuse large B-cell lymphoma. Of the 11 evaluable patients receiving the target dose of the drug, ...
 

Did You Buy These Stocks?

NASDAQ
A number of Phase 1 and 2 studies with PCI-32765 are ongoing across a panel of B-cell malignancy disorders, including chronic lymphocytic leukemia, mantle cell lymphoma, and diffuse large B-cell lymphoma. In December of 2011, Pharmacyclics inked a deal ...